Glassman Wealth Services’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-129
| Closed | -$28.4K | – | 1749 |
|
2023
Q4 | $28.4K | Buy |
129
+2
| +2% | +$440 | ﹤0.01% | 607 |
|
2023
Q3 | $28.7K | Hold |
127
| – | – | ﹤0.01% | 567 |
|
2023
Q2 | $28K | Buy |
127
+1
| +0.8% | +$221 | ﹤0.01% | 545 |
|
2023
Q1 | $28.2K | Buy |
126
+1
| +0.8% | +$224 | ﹤0.01% | 544 |
|
2022
Q4 | $34.8K | Sell |
125
-3
| -2% | -$834 | 0.01% | 511 |
|
2022
Q3 | $27K | Hold |
128
| – | – | 0.01% | 546 |
|
2022
Q2 | $30K | Hold |
128
| – | – | 0.01% | 515 |
|
2022
Q1 | $23K | Buy |
128
+6
| +5% | +$1.08K | ﹤0.01% | 610 |
|
2021
Q4 | $26K | Hold |
122
| – | – | ﹤0.01% | 542 |
|
2021
Q3 | $23K | Buy |
122
+2
| +2% | +$377 | ﹤0.01% | 552 |
|
2021
Q2 | $22K | Hold |
120
| – | – | ﹤0.01% | 554 |
|
2021
Q1 | $20K | Buy |
120
+6
| +5% | +$1K | ﹤0.01% | 536 |
|
2020
Q4 | $17K | Buy |
114
+36
| +46% | +$5.37K | ﹤0.01% | 579 |
|
2020
Q3 | $8K | Sell |
78
-4
| -5% | -$410 | ﹤0.01% | 682 |
|
2020
Q2 | $10K | Buy |
82
+63
| +332% | +$7.68K | ﹤0.01% | 500 |
|
2020
Q1 | $2K | Hold |
19
| – | – | ﹤0.01% | 758 |
|
2019
Q4 | $2K | Hold |
19
| – | – | ﹤0.01% | 801 |
|
2019
Q3 | $2K | Buy |
19
+18
| +1,800% | +$1.9K | ﹤0.01% | 746 |
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1378 |
|